Top Markets
Coin of the day
Boston Scientific Corporation Boston Scientific Corporation

Boston Scientific Corporation

BSX
Ранг среди акций #210
Boston Scientific Corporation develops, manufactures, and markets medical... Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Цена акции
$62.83
Рыночная капитализация
$93.23B
Изменение (1 день)
-9.17%
Изменение (1 год)
-31.36%
Страна
US
Торговля Boston Scientific Corporation (BSX)

Категория

Операционная маржа для Boston Scientific Corporation (BSX)
Операционная маржа на April 2026 TTM: 19.78%
Согласно последним финансовым отчетам и цене акций Boston Scientific Corporation, текущая операционная маржа (TTM) составляет 19.78%. В конце 2024 она составила 15.73%.
История операционной маржи Boston Scientific Corporation с 2000 по 2026
Операционная маржа на конец каждого года
Год Операционная маржа Изменить
2026 (TTM) 19.78% 0.00%
2025 19.78% 25.75%
2024 15.73% 2.68%
2023 15.32% 6.54%
2022 14.38% -11.07%
2021 16.17% 166.83%
2020 6.06% -62.01%
2019 15.95% -9.79%
2018 17.68% 4.93%
2017 16.85% 14.31%
2016 14.74% 39.45%
2015 10.57% -7.69%
2014 11.45% -6.07%
2013 12.19% -11.09%
2012 13.71% -6.92%
2011 14.73% 7.13%
2010 13.75% -13.58%
2009 15.91% -1.12%
2008 16.09% 13.95%
2007 14.12% -10.58%
2006 15.79% -50.98%
2005 32.21% 2.29%
2004 31.49% 57.06%
2003 20.05% -4.07%
2002 20.90% 458.82%
2001 3.74% -85.24%
2000 25.34% 0.00%
Операционная маржа для аналогичных компаний или конкурентов
Компания Операционная маржа Разница в операционной марже Страна
18.16% -99.08%
US
22.44% -98.87%
US
17.86% -99.10%
IE
17.86% -99.10%
IE
14.72% -99.26%
DE
Что такое операционная маржа компании?
Операционная маржа — это ключевой показатель прибыльности компании. Более высокая операционная маржа обычно означает, что компания может продавать свои товары или услуги значительно дороже их себестоимости. Она рассчитывается путем деления прибыли компании на её выручку.